alkenes has been researched along with Pancreatic Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engle, SK; Smith, AT; Sullivan, JM; Usborne, AL; Walgren, JL; Watson, DE | 1 |
| Bobrowski, W; Brown, TP; Evering, W; Gukasyan, HJ; Hu, W; Huang, W; John-Baptiste, A; Thibault, S; Vitsky, A; Wang, J | 1 |
2 other study(ies) available for alkenes and Pancreatic Insufficiency
| Article | Year |
|---|---|
Biomarkers of exocrine pancreatic injury in 2 rat acute pancreatitis models.
Topics: Acute Disease; Alkenes; Amylases; Animals; Biomarkers; Ceruletide; Disease Models, Animal; Dose-Response Relationship, Drug; Exocrine Pancreatic Insufficiency; Lipase; Male; MicroRNAs; Nitriles; Pancreas; Rats; Rats, Sprague-Dawley | 2014 |
Evaluation of miR-216a and miR-217 as Potential Biomarkers of Acute Exocrine Pancreatic Toxicity in Rats.
Topics: Acute Disease; Alkenes; Animals; Biomarkers; Ceruletide; Exocrine Pancreatic Insufficiency; Humans; Male; Mice, Inbred C57BL; MicroRNAs; Nitriles; Organ Specificity; Pancreas, Exocrine; Rats, Sprague-Dawley; Rats, Wistar; Sensitivity and Specificity | 2017 |